Cargando…
Development of a risk model based on immune genes in patients with colon adenocarcinoma
BACKGROUND: The rapidly increasing morbidity and the poor prognosis making the colon adenocarcinoma not only common but also highly malignant. On the other hand, immunotherapy emerges as a therapeutic modality of colon cancer recently. In this study, we developed a prognostic risk model that is base...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939989/ https://www.ncbi.nlm.nih.gov/pubmed/36058633 http://dx.doi.org/10.1002/cnr2.1712 |